ODDB.org: Open Drug Database

Atectura Breezhaler 150/160 μg, Hartkapseln mit Pulver zur Inhalation - 90

Swissmedic Key	67597004	Registration Holder	Novartis Pharma Schweiz AG
Name	Atectura Breezhaler 150/160 μg, Hartkapseln mit Pulver zur Inhalation	Date of registration	10.09.2020
		Introduction of Sequence	10.09.2020
ATC-Classification	Indacaterol and Mometasone (R03AK14)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	03.04.50.	Show package size	90
Index Therapeuticus (Swissmedic)	03.04.50.	Description
Swissmedic categorie.	B
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information	CI
Ex-factory-Price	96.74	Limitation	No

Deductible	10 %	Consumer price	121.65
Feedback	FB
GTIN	7680675970049	Medication Code	Synthetika
Pharmacode		Disponibility

Composition

indacaterolum 0.150 mg ut indacateroli acetas, mometasoni furoas 0.160 mg, lactosum monohydricum, Kapselhülle: gelatina, pro capsula.

Packungsbestandteile

Galenic Form

Inhalation Powder

Active Agent	Dose
Indacaterolum	0.15 mg
Mometasoni Furoas	0.16 mg

BAG: Active Agent	Dose
Indacaterolum	0.15 mg
Mometasone 17 Furoate	0.16 mg

Inactive agents		additional_information
Gelatina		Kapselhülle
Lactose Monohydrate
Pro Capsula

Source

Data was imported : 17.12.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2026	©ywesee GmbH